PEG-MGF – 2MG

Research Applications

1. Skeletal Muscle Injury Models & Immune-Cell Dynamics
Preclinical studies have investigated MGF-related sequences in rodent skeletal muscle injury paradigms with endpoints including inflammatory marker expression, oxidative stress markers, and immune-cell recruitment/clearance kinetics within injured tissue. These experimental designs are used to map how IGF-1 isoform–linked signaling intersects with macrophage and neutrophil resolution programs and regeneration-associated gene expression profiles.

Related mechanistic literature characterizes exercise-associated expression patterns of IGF-1 isoforms and describes in-vitro assays evaluating MGF E-domain peptide inputs, supporting their use as pathway probes in muscle cell and tissue models.

2. IGF-1 Receptor Signaling as a Mechanistic Anchor
In receptor-focused studies, full-length MGF has been evaluated for IGF-1R activation under controlled, transient exposure conditions, providing a comparative framework against recombinant IGF-1 signaling assays. These data support the use of MGF-related sequences as experimental inputs for mapping IGF-1R-driven pathway readouts (e.g., PI3K/AKT and MAPK/ERK panels) and downstream transcriptional signatures in preclinical systems.

3. Pegylated Formats for Time-Course & Distribution Studies
In time-dependent preclinical studies, short exposure windows can limit interpretation of non-pegylated peptide inputs. Pegylated formats (e.g., PEG-MGF) are therefore used in research designs that require longer circulating exposure relative to non-pegylated fragments, including single-dose time-course studies that track pathway activation and tissue distribution endpoints. Experimental discussion in the literature also highlights route and localization constraints that motivate longer-persistence peptide formats for selected model designs.

4. Cardiac Hypoxia/Ischemia Models & Cell-Death Signaling Endpoints
Bioengineering and biomaterials studies have explored localized MGF-related peptide delivery platforms in rodent cardiac hypoxia/ischemia models, measuring apoptosis-associated endpoints and recruitment of progenitor-like cell populations in injury sites. Additional work has examined polymeric microstructure delivery of MGF E-domain peptides in myocardial infarction models with hemodynamic and remodeling-associated readouts in controlled preclinical settings.

5. Osteoblast Proliferation & Bone-Defect Models
Preclinical orthopedic research has evaluated MGF E-domain peptides in rabbit bone-defect models, focusing on osteoblast proliferation markers and comparative time-course under controlled study conditions. Such work is used to investigate growth-factor axis modulation in mineralization and bone remodeling biology in animal systems.

6. Chondrocyte Migration & Mechanotransduction Pathways
Cell and tissue studies in vitro have examined MGF-related peptide inputs in mechanical overload contexts, with mechanistic emphasis on RhoA/YAP-associated signaling and migration behavior of growth plate chondrocytes. These models support use of MGF-derived peptides as probes for mechanotransduction-linked pathways in cartilage-relevant research.

7. Periodontal Ligament Cell Models & MEK/ERK Signaling
In vitro studies using periodontal ligament cell cultures have investigated stretch-associated osteogenic differentiation programs and matrix metalloproteinase expression (e.g., MMP-1, MMP-2), with mechanistic focus on MEK/ERK pathway activation.

8. CNS Context & Technical Literature
Preclinical reports and reviews have discussed MGF-related sequences in CNS contexts, including animal models of neuron injury and ischemia, with emphasis on cell-survival–associated markers and functional readouts measured in vivo.

⚠️ Important Warnings and Disclaimers

Product Guidelines

• Product intended for experimental and research purposes only.

• Do not use without proper technical knowledge.

• Keep refrigerated as per storage guidelines.

• Results may vary based on genetics, diet, and lifestyle.

• Keep out of reach of children.

• Store according to technical instructions.

• Do not reuse vials or materials.

• Do not purchase if you have any doubts regarding its use.

Limitation of Liability The company is not responsible for:

• Misuse or incorrect administration.

• Adverse reactions or interactions with other medications.

• Consequences resulting from self-medication.

• The buyer assumes full responsibility for all risks associated with handling and utilization.

📌 Legal Compliance This product is marketed as a research chemical, in compliance with international laboratory supply practices. The sale of this product does not constitute an offer for medical treatment.